GENE ONLINE|News &
Opinion
Blog

Alzheimer's Disease
Trials & Approvals AHEAD 3-45
FDA Grants Breakthrough Status to Two Experimental Alzheimer’s Drugs While Pushback Over Aduhelm’s Approval Still Rages On
2021-06-25
Trials & Approvals
Biogen’s Controversial Alzheimer’s Drug Wins Historic FDA Approval
2021-06-07
Technology CRISPR
Novel CRISPR Screen Unravels Disease-Related Genes in Neurons
2021-05-31
Special Alzheimer's Disease
Towards Exosome-Based Theranostics for Alzheimer’s Disease
2021-04-19
R&D Alzheimer's Disease
Lilly’s Positive Data for Alzheimer’s Drug Bodes Well for Candidates Rooted in Amyloid Hypothesis
2021-03-14
Trials & Approvals Alzheimer's Disease
Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
2021-01-21
Trials & Approvals
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
COVID-19
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
Trials & Approvals Alzheimer's Disease
Biogen’s Alzheimer’s Drug Turned Down by Independent Panel
2020-11-07
Trials & Approvals Alzheimer's Disease
Biogen Stocks Rise Following FDA’s Inspiriting Comments on Alzheimer’s Drug, Aducanumab
2020-11-05
COVID-19 AI
Spotlight: An AI Method to Determine Asymptomatic COVID-19 Patients
2020-11-05
R&D Alzheimer's Disease
Availability of C2N’s First Blood-Based Diagnostic Marks Breakthrough in Alzheimer’s Disease
2020-10-30
Trials & Approvals Alzheimer's Disease
Roche, AC Immune’s Alzheimer’s Drug Joins Long List of Trial Flops
2020-09-25
Trials & Approvals Huntington's Disease
Vaccinex’s Drug Flounders Huntington’s Trial, but Shows Promise against Another Neurodegenerative Disease
2020-09-24
R&D Alzheimer's Disease
Alzheon’s Bags $47 Million from NIA for Oral Alzheimer’s Drug
2020-08-22
1 2 3 4 5
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top